| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Profiling | 51 | 2023 | 1910 | 5.220 |
Why?
|
| Tumor Microenvironment | 16 | 2024 | 690 | 4.010 |
Why?
|
| Breast Neoplasms | 25 | 2022 | 2763 | 3.740 |
Why?
|
| Gene Regulatory Networks | 20 | 2018 | 397 | 2.890 |
Why?
|
| Transcription Factors | 35 | 2017 | 2704 | 2.800 |
Why?
|
| E2F4 Transcription Factor | 5 | 2022 | 10 | 2.760 |
Why?
|
| Gene Expression Regulation, Neoplastic | 24 | 2022 | 2122 | 2.680 |
Why?
|
| Computational Biology | 18 | 2019 | 887 | 2.600 |
Why?
|
| Lung Neoplasms | 8 | 2024 | 1788 | 2.190 |
Why?
|
| Biomarkers, Tumor | 13 | 2022 | 1720 | 2.130 |
Why?
|
| Transcriptome | 15 | 2022 | 1127 | 2.020 |
Why?
|
| Prognosis | 30 | 2024 | 5081 | 2.000 |
Why?
|
| Neoplasms | 14 | 2024 | 3027 | 1.950 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 15 | 2011 | 1070 | 1.860 |
Why?
|
| Chromatin | 13 | 2022 | 609 | 1.740 |
Why?
|
| Genomics | 15 | 2022 | 1676 | 1.730 |
Why?
|
| Gene Expression Regulation | 21 | 2022 | 2656 | 1.560 |
Why?
|
| Chromatin Immunoprecipitation | 14 | 2022 | 248 | 1.520 |
Why?
|
| Saccharomyces cerevisiae | 10 | 2018 | 435 | 1.410 |
Why?
|
| Molecular Sequence Annotation | 9 | 2017 | 162 | 1.310 |
Why?
|
| MicroRNAs | 10 | 2016 | 951 | 1.300 |
Why?
|
| Gene Expression | 9 | 2018 | 1614 | 1.300 |
Why?
|
| Algorithms | 21 | 2019 | 1736 | 1.280 |
Why?
|
| Sequence Analysis, RNA | 12 | 2024 | 428 | 1.260 |
Why?
|
| Gene Expression Regulation, Fungal | 8 | 2017 | 58 | 1.180 |
Why?
|
| DNA Methylation | 8 | 2019 | 1143 | 1.170 |
Why?
|
| Receptors, Estrogen | 8 | 2021 | 828 | 1.160 |
Why?
|
| Survival Analysis | 14 | 2021 | 1596 | 1.160 |
Why?
|
| Macrophages | 3 | 2024 | 704 | 1.150 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 2024 | 137 | 1.130 |
Why?
|
| STAT3 Transcription Factor | 3 | 2019 | 230 | 1.130 |
Why?
|
| Melanoma | 5 | 2023 | 975 | 1.120 |
Why?
|
| Genome, Human | 13 | 2018 | 1350 | 1.080 |
Why?
|
| Models, Genetic | 13 | 2020 | 789 | 1.070 |
Why?
|
| Hematopoiesis | 4 | 2016 | 229 | 1.040 |
Why?
|
| Immunotherapy | 7 | 2024 | 749 | 1.040 |
Why?
|
| Databases, Genetic | 10 | 2022 | 501 | 1.040 |
Why?
|
| Histones | 8 | 2014 | 568 | 1.030 |
Why?
|
| Transcription, Genetic | 13 | 2017 | 1757 | 1.020 |
Why?
|
| Humans | 118 | 2024 | 133943 | 1.010 |
Why?
|
| RNA, Untranslated | 7 | 2014 | 120 | 0.980 |
Why?
|
| Caenorhabditis elegans | 9 | 2016 | 245 | 0.970 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2019 | 569 | 0.960 |
Why?
|
| Binding Sites | 16 | 2022 | 1370 | 0.920 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2022 | 2940 | 0.910 |
Why?
|
| CpG Islands | 7 | 2019 | 347 | 0.900 |
Why?
|
| Cell Communication | 3 | 2023 | 186 | 0.900 |
Why?
|
| Paraproteinemias | 1 | 2024 | 22 | 0.870 |
Why?
|
| Adenocarcinoma | 4 | 2019 | 1070 | 0.860 |
Why?
|
| Databases, Nucleic Acid | 5 | 2020 | 74 | 0.850 |
Why?
|
| Gene Amplification | 2 | 2021 | 247 | 0.830 |
Why?
|
| Epigenomics | 2 | 2022 | 195 | 0.830 |
Why?
|
| Data Mining | 2 | 2014 | 58 | 0.790 |
Why?
|
| Mutation | 11 | 2022 | 6297 | 0.760 |
Why?
|
| Up-Regulation | 5 | 2021 | 905 | 0.750 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2020 | 217 | 0.750 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2024 | 113 | 0.740 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 792 | 0.730 |
Why?
|
| Multiple Myeloma | 1 | 2024 | 201 | 0.730 |
Why?
|
| Sequence Analysis, DNA | 11 | 2017 | 1833 | 0.720 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2021 | 55 | 0.720 |
Why?
|
| Chromosomes, Human, 19-20 | 1 | 2021 | 2 | 0.720 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2022 | 92 | 0.710 |
Why?
|
| Pleural Neoplasms | 1 | 2022 | 82 | 0.710 |
Why?
|
| Mesothelioma | 1 | 2022 | 94 | 0.710 |
Why?
|
| Cell Line, Tumor | 15 | 2021 | 3751 | 0.700 |
Why?
|
| Galectin 3 | 3 | 2016 | 37 | 0.680 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2012 | 170 | 0.680 |
Why?
|
| Quantitative Trait Loci | 1 | 2022 | 319 | 0.670 |
Why?
|
| Microsatellite Repeats | 1 | 2021 | 240 | 0.670 |
Why?
|
| Cell Cycle | 4 | 2013 | 626 | 0.670 |
Why?
|
| Antineoplastic Agents | 5 | 2019 | 1850 | 0.660 |
Why?
|
| Computer Simulation | 5 | 2022 | 701 | 0.660 |
Why?
|
| Rectal Neoplasms | 1 | 2021 | 83 | 0.650 |
Why?
|
| Cytogenetic Analysis | 1 | 2019 | 82 | 0.650 |
Why?
|
| Saccharomyces cerevisiae Proteins | 7 | 2018 | 283 | 0.640 |
Why?
|
| Evolution, Molecular | 8 | 2016 | 709 | 0.630 |
Why?
|
| Precision Medicine | 2 | 2022 | 355 | 0.630 |
Why?
|
| Skin Neoplasms | 4 | 2021 | 907 | 0.630 |
Why?
|
| Endometriosis | 3 | 2017 | 184 | 0.620 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2022 | 1139 | 0.610 |
Why?
|
| E2F1 Transcription Factor | 2 | 2016 | 51 | 0.610 |
Why?
|
| B7 Antigens | 4 | 2020 | 14 | 0.600 |
Why?
|
| Promoter Regions, Genetic | 11 | 2022 | 1418 | 0.590 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2018 | 38 | 0.590 |
Why?
|
| Software | 4 | 2020 | 737 | 0.580 |
Why?
|
| RNA, Messenger | 14 | 2022 | 2902 | 0.570 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 271 | 0.570 |
Why?
|
| Neuroblastoma | 2 | 2020 | 539 | 0.570 |
Why?
|
| Recombinational DNA Repair | 1 | 2017 | 19 | 0.570 |
Why?
|
| Cell Cycle Checkpoints | 3 | 2018 | 62 | 0.570 |
Why?
|
| Genome | 3 | 2019 | 526 | 0.560 |
Why?
|
| Female | 45 | 2022 | 71684 | 0.560 |
Why?
|
| Base Sequence | 18 | 2019 | 3170 | 0.550 |
Why?
|
| Models, Statistical | 5 | 2012 | 505 | 0.550 |
Why?
|
| Protein Binding | 10 | 2022 | 1832 | 0.540 |
Why?
|
| Leukocytes | 1 | 2018 | 225 | 0.540 |
Why?
|
| Proportional Hazards Models | 6 | 2018 | 1484 | 0.540 |
Why?
|
| Genes, Neoplasm | 2 | 2017 | 90 | 0.530 |
Why?
|
| Animals | 42 | 2021 | 36388 | 0.510 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2016 | 97 | 0.510 |
Why?
|
| Cell Proliferation | 11 | 2019 | 2539 | 0.510 |
Why?
|
| Neoadjuvant Therapy | 4 | 2022 | 404 | 0.500 |
Why?
|
| Encyclopedias as Topic | 2 | 2012 | 7 | 0.500 |
Why?
|
| Disease Progression | 4 | 2019 | 2242 | 0.500 |
Why?
|
| Liposarcoma | 1 | 2016 | 25 | 0.500 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 97 | 0.490 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 1315 | 0.480 |
Why?
|
| Genes, p53 | 3 | 2022 | 234 | 0.480 |
Why?
|
| User-Computer Interface | 1 | 2016 | 166 | 0.480 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 773 | 0.470 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2016 | 962 | 0.470 |
Why?
|
| Mycobacterium bovis | 1 | 2015 | 31 | 0.470 |
Why?
|
| DNA Copy Number Variations | 5 | 2021 | 1022 | 0.470 |
Why?
|
| Infertility | 1 | 2016 | 82 | 0.460 |
Why?
|
| RNA Interference | 1 | 2016 | 544 | 0.460 |
Why?
|
| Oxidative Stress | 4 | 2016 | 870 | 0.450 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2016 | 141 | 0.450 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 291 | 0.450 |
Why?
|
| Genome, Fungal | 2 | 2011 | 34 | 0.450 |
Why?
|
| Signal Transduction | 13 | 2018 | 4899 | 0.440 |
Why?
|
| Survival Rate | 8 | 2022 | 2210 | 0.440 |
Why?
|
| Leukemia | 2 | 2016 | 380 | 0.440 |
Why?
|
| Conserved Sequence | 7 | 2014 | 298 | 0.430 |
Why?
|
| Estrogen Receptor alpha | 3 | 2015 | 474 | 0.430 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 734 | 0.420 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 697 | 0.400 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 874 | 0.390 |
Why?
|
| T-Lymphocytes | 3 | 2020 | 1814 | 0.390 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2021 | 444 | 0.380 |
Why?
|
| Homeostasis | 1 | 2016 | 746 | 0.380 |
Why?
|
| Carcinoma | 1 | 2014 | 322 | 0.380 |
Why?
|
| Amino Acid Motifs | 5 | 2015 | 204 | 0.370 |
Why?
|
| Phosphorylation | 2 | 2015 | 1701 | 0.370 |
Why?
|
| Internet | 4 | 2016 | 402 | 0.370 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 757 | 0.370 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 815 | 0.360 |
Why?
|
| Transcription Initiation Site | 5 | 2014 | 34 | 0.360 |
Why?
|
| Biomarkers | 2 | 2022 | 3426 | 0.350 |
Why?
|
| Cluster Analysis | 6 | 2015 | 438 | 0.350 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2022 | 821 | 0.340 |
Why?
|
| 3' Untranslated Regions | 2 | 2019 | 182 | 0.340 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 177 | 0.340 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 556 | 0.330 |
Why?
|
| Mice | 21 | 2021 | 18909 | 0.330 |
Why?
|
| Chromosomal Instability | 2 | 2021 | 63 | 0.330 |
Why?
|
| Glioblastoma | 3 | 2019 | 375 | 0.320 |
Why?
|
| DNA | 2 | 2012 | 1675 | 0.320 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2016 | 885 | 0.320 |
Why?
|
| Organ Specificity | 7 | 2016 | 444 | 0.320 |
Why?
|
| Ubiquitin-Specific Proteases | 2 | 2021 | 20 | 0.320 |
Why?
|
| Case-Control Studies | 6 | 2021 | 3639 | 0.310 |
Why?
|
| SEER Program | 2 | 2021 | 224 | 0.300 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 348 | 0.300 |
Why?
|
| Ovarian Neoplasms | 3 | 2020 | 464 | 0.300 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2021 | 401 | 0.290 |
Why?
|
| ROC Curve | 2 | 2022 | 616 | 0.280 |
Why?
|
| BRCA1 Protein | 2 | 2019 | 82 | 0.280 |
Why?
|
| DNA, Complementary | 6 | 2003 | 472 | 0.280 |
Why?
|
| Molecular Sequence Data | 15 | 2013 | 3967 | 0.270 |
Why?
|
| Brain Neoplasms | 4 | 2018 | 1409 | 0.270 |
Why?
|
| Progesterone | 3 | 2017 | 631 | 0.270 |
Why?
|
| Apoptosis | 9 | 2019 | 1930 | 0.270 |
Why?
|
| Endometrium | 3 | 2017 | 287 | 0.270 |
Why?
|
| Models, Biological | 7 | 2018 | 1532 | 0.270 |
Why?
|
| Fungal Proteins | 3 | 2017 | 142 | 0.260 |
Why?
|
| HL-60 Cells | 2 | 2016 | 34 | 0.260 |
Why?
|
| Hypoxia | 2 | 2019 | 264 | 0.260 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2016 | 90 | 0.250 |
Why?
|
| Aspergillus fumigatus | 2 | 2017 | 44 | 0.250 |
Why?
|
| Genome-Wide Association Study | 5 | 2018 | 1871 | 0.250 |
Why?
|
| Longevity | 1 | 2007 | 158 | 0.250 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 352 | 0.250 |
Why?
|
| Proteomics | 2 | 2022 | 592 | 0.240 |
Why?
|
| Membrane Proteins | 3 | 2020 | 1606 | 0.240 |
Why?
|
| RNA-Binding Proteins | 5 | 2017 | 609 | 0.240 |
Why?
|
| Drug Discovery | 2 | 2016 | 182 | 0.230 |
Why?
|
| Drosophila melanogaster | 4 | 2014 | 837 | 0.230 |
Why?
|
| HeLa Cells | 4 | 2016 | 828 | 0.230 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 2161 | 0.220 |
Why?
|
| Microsatellite Instability | 2 | 2021 | 43 | 0.220 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 971 | 0.220 |
Why?
|
| Plasma Cells | 1 | 2024 | 57 | 0.210 |
Why?
|
| Genes, cdc | 2 | 2013 | 25 | 0.210 |
Why?
|
| Colorectal Neoplasms | 2 | 2021 | 648 | 0.210 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2018 | 644 | 0.210 |
Why?
|
| Ribosomes | 3 | 2015 | 139 | 0.210 |
Why?
|
| Treatment Outcome | 5 | 2022 | 13013 | 0.210 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 2 | 2014 | 75 | 0.210 |
Why?
|
| Cell Line | 6 | 2017 | 2836 | 0.200 |
Why?
|
| Transcription Factor AP-1 | 1 | 2022 | 111 | 0.200 |
Why?
|
| Nucleotide Motifs | 4 | 2017 | 48 | 0.190 |
Why?
|
| Yeasts | 2 | 2015 | 43 | 0.190 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2019 | 104 | 0.190 |
Why?
|
| Mutation Rate | 1 | 2022 | 73 | 0.190 |
Why?
|
| Glioma | 2 | 2017 | 537 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2015 | 563 | 0.190 |
Why?
|
| Estrogens | 2 | 2016 | 522 | 0.180 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 38 | 0.180 |
Why?
|
| RNA Stability | 1 | 2022 | 84 | 0.180 |
Why?
|
| Artificial Intelligence | 3 | 2014 | 297 | 0.180 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 550 | 0.180 |
Why?
|
| Medical History Taking | 1 | 2021 | 118 | 0.180 |
Why?
|
| Estradiol | 2 | 2016 | 552 | 0.180 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 48 | 0.180 |
Why?
|
| Neutrophil Infiltration | 1 | 2021 | 66 | 0.180 |
Why?
|
| Models, Theoretical | 2 | 2022 | 397 | 0.180 |
Why?
|
| Tumor Cells, Cultured | 6 | 2019 | 1102 | 0.180 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 7212 | 0.170 |
Why?
|
| Genes, ras | 1 | 2021 | 102 | 0.170 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 2 | 2017 | 28 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 1079 | 0.170 |
Why?
|
| Genes, Fungal | 3 | 2014 | 64 | 0.170 |
Why?
|
| Chromones | 2 | 2017 | 26 | 0.170 |
Why?
|
| Aged | 6 | 2021 | 21746 | 0.170 |
Why?
|
| Peripheral Tolerance | 1 | 2020 | 4 | 0.170 |
Why?
|
| Male | 14 | 2021 | 65904 | 0.170 |
Why?
|
| Immunologic Memory | 1 | 2021 | 199 | 0.160 |
Why?
|
| Schizosaccharomyces | 2 | 2018 | 66 | 0.160 |
Why?
|
| Morpholines | 2 | 2017 | 64 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2018 | 351 | 0.160 |
Why?
|
| CD36 Antigens | 1 | 2019 | 42 | 0.160 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 58 | 0.160 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2019 | 38 | 0.160 |
Why?
|
| Cloning, Molecular | 9 | 2003 | 911 | 0.160 |
Why?
|
| Lymph Nodes | 1 | 2021 | 397 | 0.160 |
Why?
|
| Support Vector Machine | 1 | 2019 | 22 | 0.160 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 224 | 0.150 |
Why?
|
| MCF-7 Cells | 2 | 2016 | 232 | 0.150 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 51 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 2 | 2017 | 205 | 0.150 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2018 | 38 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 183 | 0.150 |
Why?
|
| Species Specificity | 4 | 2014 | 570 | 0.150 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2018 | 37 | 0.150 |
Why?
|
| Exons | 5 | 2012 | 832 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2020 | 501 | 0.150 |
Why?
|
| Huntingtin Protein | 1 | 2018 | 65 | 0.150 |
Why?
|
| Mice, Nude | 2 | 2019 | 777 | 0.150 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2018 | 45 | 0.140 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2018 | 136 | 0.140 |
Why?
|
| Lymphokines | 1 | 2018 | 69 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 506 | 0.140 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 151 | 0.140 |
Why?
|
| Immune System | 1 | 2018 | 98 | 0.140 |
Why?
|
| Centromere Protein B | 1 | 2017 | 2 | 0.140 |
Why?
|
| Lentivirus | 1 | 2018 | 86 | 0.140 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2017 | 320 | 0.140 |
Why?
|
| Protein Interaction Mapping | 3 | 2015 | 94 | 0.140 |
Why?
|
| Catabolite Repression | 1 | 2017 | 1 | 0.140 |
Why?
|
| Sequence Alignment | 3 | 2008 | 630 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 118 | 0.140 |
Why?
|
| Logistic Models | 2 | 2015 | 1908 | 0.140 |
Why?
|
| Cation Transport Proteins | 2 | 2016 | 100 | 0.140 |
Why?
|
| Fatty Acids | 1 | 2019 | 370 | 0.140 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 20 | 0.140 |
Why?
|
| GATA1 Transcription Factor | 2 | 2014 | 9 | 0.140 |
Why?
|
| Phosphoproteins | 2 | 2017 | 456 | 0.140 |
Why?
|
| Aspergillosis | 1 | 2017 | 47 | 0.130 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 136 | 0.130 |
Why?
|
| Data Curation | 1 | 2017 | 14 | 0.130 |
Why?
|
| B7-H1 Antigen | 1 | 2018 | 133 | 0.130 |
Why?
|
| RNA Caps | 1 | 2016 | 32 | 0.130 |
Why?
|
| Rad51 Recombinase | 1 | 2016 | 32 | 0.130 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 63 | 0.130 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 70 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 542 | 0.130 |
Why?
|
| Genetic Pleiotropy | 1 | 2016 | 26 | 0.130 |
Why?
|
| Risk Factors | 2 | 2021 | 11101 | 0.130 |
Why?
|
| Androstadienes | 1 | 2016 | 52 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2016 | 1134 | 0.130 |
Why?
|
| Age Factors | 2 | 2021 | 2979 | 0.130 |
Why?
|
| Neuropeptides | 1 | 2017 | 115 | 0.130 |
Why?
|
| Computer-Aided Design | 1 | 2016 | 22 | 0.130 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 498 | 0.130 |
Why?
|
| Adult | 6 | 2021 | 31950 | 0.130 |
Why?
|
| Carbon | 1 | 2017 | 99 | 0.130 |
Why?
|
| Breast | 2 | 2019 | 218 | 0.130 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2017 | 95 | 0.130 |
Why?
|
| Time Factors | 6 | 2013 | 6590 | 0.130 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2016 | 3 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2016 | 19 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 159 | 0.130 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 267 | 0.130 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 368 | 0.130 |
Why?
|
| Molecular Docking Simulation | 1 | 2016 | 127 | 0.130 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 246 | 0.130 |
Why?
|
| Methyltransferases | 1 | 2016 | 82 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2017 | 280 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2016 | 135 | 0.120 |
Why?
|
| Proteins | 2 | 2012 | 1087 | 0.120 |
Why?
|
| Receptor, ErbB-2 | 1 | 2019 | 559 | 0.120 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2014 | 175 | 0.120 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2015 | 11 | 0.120 |
Why?
|
| Smoking | 1 | 2021 | 1139 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 260 | 0.120 |
Why?
|
| Mitosis | 1 | 2016 | 194 | 0.120 |
Why?
|
| Middle Aged | 6 | 2021 | 29409 | 0.120 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 142 | 0.120 |
Why?
|
| Drug Design | 1 | 2016 | 168 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 286 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2017 | 1045 | 0.120 |
Why?
|
| Cytokines | 2 | 2018 | 1396 | 0.120 |
Why?
|
| Genes, Regulator | 1 | 2015 | 57 | 0.120 |
Why?
|
| Programming Languages | 1 | 2015 | 19 | 0.120 |
Why?
|
| beta Catenin | 1 | 2016 | 229 | 0.120 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 1334 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2016 | 3475 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 407 | 0.120 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2014 | 3 | 0.120 |
Why?
|
| Neurospora crassa | 1 | 2014 | 5 | 0.120 |
Why?
|
| Genomic Instability | 1 | 2016 | 244 | 0.120 |
Why?
|
| Terminator Regions, Genetic | 1 | 2014 | 8 | 0.120 |
Why?
|
| Sirolimus | 1 | 2016 | 253 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 139 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 233 | 0.110 |
Why?
|
| Protein Biosynthesis | 2 | 2015 | 676 | 0.110 |
Why?
|
| Tissue Distribution | 4 | 2002 | 400 | 0.110 |
Why?
|
| DNA Repair | 2 | 2016 | 630 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 2 | 2020 | 1069 | 0.110 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 746 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2016 | 313 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2015 | 333 | 0.110 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 317 | 0.110 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2015 | 130 | 0.110 |
Why?
|
| Lung | 1 | 2022 | 1557 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 456 | 0.110 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2014 | 28 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 508 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 112 | 0.110 |
Why?
|
| E2F Transcription Factors | 1 | 2013 | 26 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2014 | 49 | 0.110 |
Why?
|
| Circadian Clocks | 1 | 2014 | 71 | 0.110 |
Why?
|
| Epithelial Cells | 2 | 2016 | 941 | 0.110 |
Why?
|
| Acetophenones | 1 | 2013 | 13 | 0.110 |
Why?
|
| Receptors, GABA-A | 1 | 2013 | 59 | 0.110 |
Why?
|
| Diploidy | 1 | 2013 | 39 | 0.100 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 718 | 0.100 |
Why?
|
| Amino Acid Sequence | 9 | 2003 | 2781 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2021 | 17488 | 0.100 |
Why?
|
| DNA Footprinting | 1 | 2012 | 14 | 0.100 |
Why?
|
| Deoxyribonuclease I | 1 | 2012 | 52 | 0.100 |
Why?
|
| Base Composition | 1 | 2012 | 75 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 1386 | 0.100 |
Why?
|
| K562 Cells | 3 | 2019 | 100 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2003 | 673 | 0.100 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 137 | 0.100 |
Why?
|
| Lymphocyte Activation | 3 | 2020 | 724 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2017 | 1242 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 486 | 0.090 |
Why?
|
| STAT4 Transcription Factor | 1 | 2011 | 9 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 510 | 0.090 |
Why?
|
| RNA | 1 | 2015 | 601 | 0.090 |
Why?
|
| Gene Components | 1 | 2011 | 8 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 761 | 0.090 |
Why?
|
| Acetylation | 1 | 2011 | 183 | 0.090 |
Why?
|
| Mammals | 1 | 2012 | 277 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 381 | 0.090 |
Why?
|
| Alcoholism | 1 | 2013 | 249 | 0.090 |
Why?
|
| Genome, Helminth | 1 | 2010 | 12 | 0.090 |
Why?
|
| Quality Control | 1 | 2011 | 127 | 0.090 |
Why?
|
| Chorionic Gonadotropin | 1 | 2011 | 79 | 0.090 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 611 | 0.090 |
Why?
|
| Alleles | 2 | 2012 | 1705 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2002 | 145 | 0.090 |
Why?
|
| Systems Biology | 1 | 2010 | 63 | 0.090 |
Why?
|
| Pseudogenes | 1 | 2010 | 53 | 0.080 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2010 | 81 | 0.080 |
Why?
|
| Genome, Insect | 1 | 2011 | 116 | 0.080 |
Why?
|
| Protein Interaction Maps | 3 | 2016 | 89 | 0.080 |
Why?
|
| Chromosomes | 1 | 2010 | 164 | 0.080 |
Why?
|
| Trophoblasts | 1 | 2011 | 119 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 392 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2016 | 3167 | 0.080 |
Why?
|
| Argonaute Proteins | 1 | 2009 | 31 | 0.080 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2009 | 37 | 0.080 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2009 | 9 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 616 | 0.080 |
Why?
|
| Histone Deacetylases | 2 | 2011 | 122 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 54 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2015 | 1002 | 0.080 |
Why?
|
| Sarcomeres | 1 | 2009 | 34 | 0.080 |
Why?
|
| Transcription Factor AP-2 | 2 | 2015 | 23 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2013 | 3056 | 0.080 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 318 | 0.080 |
Why?
|
| Ribonuclease III | 1 | 2009 | 103 | 0.080 |
Why?
|
| Down-Regulation | 3 | 2019 | 717 | 0.080 |
Why?
|
| DNA Probes | 1 | 2008 | 125 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 1326 | 0.070 |
Why?
|
| Phenotype | 2 | 2018 | 4548 | 0.070 |
Why?
|
| Free Radicals | 1 | 2007 | 39 | 0.070 |
Why?
|
| Receptors, Steroid | 1 | 2009 | 276 | 0.070 |
Why?
|
| Primary Cell Culture | 2 | 2017 | 110 | 0.070 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2018 | 172 | 0.070 |
Why?
|
| Cytosol | 1 | 2007 | 168 | 0.070 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2022 | 124 | 0.070 |
Why?
|
| Caloric Restriction | 1 | 2007 | 88 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 170 | 0.070 |
Why?
|
| ras Proteins | 1 | 2007 | 146 | 0.070 |
Why?
|
| Actins | 1 | 2009 | 351 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 406 | 0.060 |
Why?
|
| Brain | 3 | 2005 | 3221 | 0.060 |
Why?
|
| Zebrafish | 1 | 2009 | 417 | 0.060 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2005 | 9 | 0.060 |
Why?
|
| Pongo pygmaeus | 1 | 2005 | 7 | 0.060 |
Why?
|
| Tacrolimus | 1 | 2006 | 107 | 0.060 |
Why?
|
| Sirtuins | 1 | 2005 | 16 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2005 | 98 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2005 | 75 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2012 | 1621 | 0.060 |
Why?
|
| Testis | 3 | 2001 | 426 | 0.060 |
Why?
|
| Chromosome Mapping | 3 | 2002 | 1123 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 240 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 699 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2024 | 90 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2002 | 781 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 2 | 2015 | 198 | 0.050 |
Why?
|
| United States | 1 | 2018 | 11687 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2015 | 75 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2024 | 253 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2003 | 142 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 388 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 1052 | 0.050 |
Why?
|
| Receptors, Angiotensin | 1 | 2002 | 21 | 0.050 |
Why?
|
| Protein Array Analysis | 1 | 2022 | 107 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 4777 | 0.050 |
Why?
|
| Vitiligo | 1 | 2021 | 8 | 0.050 |
Why?
|
| Microtubule Proteins | 1 | 2001 | 29 | 0.050 |
Why?
|
| Stress, Physiological | 2 | 2017 | 271 | 0.050 |
Why?
|
| Peptides | 3 | 2018 | 859 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2024 | 407 | 0.040 |
Why?
|
| Calcium | 1 | 2006 | 1146 | 0.040 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2001 | 17 | 0.040 |
Why?
|
| Cyclophilins | 1 | 2001 | 20 | 0.040 |
Why?
|
| Introns | 4 | 2003 | 313 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2002 | 258 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 371 | 0.040 |
Why?
|
| Cell Movement | 2 | 2017 | 916 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2001 | 103 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 2015 | 130 | 0.040 |
Why?
|
| Reference Values | 2 | 2013 | 742 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5511 | 0.040 |
Why?
|
| Cell Growth Processes | 1 | 2019 | 69 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4822 | 0.040 |
Why?
|
| Anemia | 1 | 2003 | 351 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 104 | 0.040 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2018 | 31 | 0.040 |
Why?
|
| Homologous Recombination | 1 | 2019 | 100 | 0.040 |
Why?
|
| Response Elements | 2 | 2009 | 106 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2018 | 90 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 199 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 5182 | 0.040 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2018 | 50 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 307 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 67 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 2017 | 11 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2018 | 55 | 0.040 |
Why?
|
| Ovary | 1 | 2001 | 384 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2018 | 60 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2018 | 311 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 152 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2018 | 123 | 0.040 |
Why?
|
| Androgen Antagonists | 1 | 2018 | 131 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2012 | 220 | 0.030 |
Why?
|
| Tyrphostins | 1 | 2017 | 13 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2017 | 50 | 0.030 |
Why?
|
| Fetus | 1 | 2001 | 599 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2017 | 55 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2017 | 203 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 247 | 0.030 |
Why?
|
| Genes, myc | 1 | 2016 | 107 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 613 | 0.030 |
Why?
|
| Telomerase | 1 | 2017 | 179 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 132 | 0.030 |
Why?
|
| Pyrazines | 1 | 2017 | 73 | 0.030 |
Why?
|
| Epithelium | 1 | 2017 | 370 | 0.030 |
Why?
|
| Primates | 1 | 2016 | 87 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 572 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 231 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 1006 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2016 | 35 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2001 | 1066 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 263 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 399 | 0.030 |
Why?
|
| Thiazoles | 1 | 2016 | 102 | 0.030 |
Why?
|
| Imidazoles | 1 | 2017 | 217 | 0.030 |
Why?
|
| Flavonoids | 1 | 2016 | 87 | 0.030 |
Why?
|
| Quinolines | 1 | 2016 | 112 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2015 | 40 | 0.030 |
Why?
|
| Unsupervised Machine Learning | 1 | 2015 | 14 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 230 | 0.030 |
Why?
|
| Protein Kinases | 2 | 2007 | 343 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 611 | 0.030 |
Why?
|
| Knowledge Bases | 1 | 2015 | 40 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 43 | 0.030 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 87 | 0.030 |
Why?
|
| Pupa | 1 | 2014 | 23 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2019 | 897 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 72 | 0.030 |
Why?
|
| Transfection | 1 | 2016 | 1089 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2017 | 363 | 0.030 |
Why?
|
| Piperidines | 1 | 2016 | 239 | 0.030 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Polycomb-Group Proteins | 1 | 2013 | 22 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 52 | 0.030 |
Why?
|
| Larva | 1 | 2014 | 262 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 279 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 248 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2015 | 631 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2016 | 332 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2013 | 63 | 0.030 |
Why?
|
| Histone Acetyltransferases | 1 | 2014 | 317 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1315 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 111 | 0.030 |
Why?
|
| PPAR delta | 1 | 2013 | 10 | 0.030 |
Why?
|
| Intestines | 1 | 2017 | 614 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2013 | 98 | 0.030 |
Why?
|
| Staurosporine | 1 | 2012 | 22 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 334 | 0.020 |
Why?
|
| Multigene Family | 1 | 2013 | 323 | 0.020 |
Why?
|
| Poly A | 1 | 2012 | 60 | 0.020 |
Why?
|
| Neurons | 1 | 2002 | 2035 | 0.020 |
Why?
|
| Stem Cells | 1 | 2017 | 753 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 2526 | 0.020 |
Why?
|
| Pregnancy | 2 | 2002 | 7522 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 433 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2017 | 869 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2012 | 168 | 0.020 |
Why?
|
| Insulin | 1 | 2017 | 1246 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3981 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 844 | 0.020 |
Why?
|
| Insulator Elements | 1 | 2011 | 3 | 0.020 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2011 | 6 | 0.020 |
Why?
|
| Integrin beta1 | 1 | 2011 | 56 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2010 | 9 | 0.020 |
Why?
|
| Genes, Helminth | 1 | 2010 | 22 | 0.020 |
Why?
|
| Gene Library | 2 | 2001 | 225 | 0.020 |
Why?
|
| DNA, Intergenic | 1 | 2010 | 19 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 889 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2010 | 102 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 484 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 1337 | 0.020 |
Why?
|
| Electron Transport | 1 | 2009 | 56 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2010 | 135 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2010 | 114 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 2009 | 62 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2009 | 50 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 774 | 0.020 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 73 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1735 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 812 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 363 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2011 | 234 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2009 | 128 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2010 | 366 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2010 | 303 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2010 | 371 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 1000 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 243 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2009 | 128 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 395 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2007 | 79 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 1355 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 2807 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2007 | 262 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 330 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 1411 | 0.020 |
Why?
|
| Aging | 1 | 2013 | 1302 | 0.020 |
Why?
|
| Sirtuin 2 | 1 | 2005 | 6 | 0.020 |
Why?
|
| Vitamin K 3 | 1 | 2005 | 5 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2005 | 23 | 0.020 |
Why?
|
| Adenylyl Cyclases | 1 | 2005 | 89 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2005 | 145 | 0.010 |
Why?
|
| Ethanol | 1 | 2005 | 171 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 809 | 0.010 |
Why?
|
| Receptors for Activated C Kinase | 1 | 2002 | 6 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 67 | 0.010 |
Why?
|
| Spermatids | 1 | 2001 | 27 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 270 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2002 | 64 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 253 | 0.010 |
Why?
|
| Dogs | 1 | 2001 | 799 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2001 | 102 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2001 | 336 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 991 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2001 | 149 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2001 | 374 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9890 | 0.010 |
Why?
|
| Phylogeny | 1 | 2001 | 784 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1438 | 0.010 |
Why?
|
| Prostate | 1 | 2001 | 448 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 619 | 0.010 |
Why?
|
| Myocardium | 1 | 2001 | 1045 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 20536 | 0.010 |
Why?
|
| Rats | 1 | 2001 | 3883 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 1623 | 0.010 |
Why?
|